PROCEPT BioRobotics Corporation (PRCT) Payables and obligations
- Other obligations · latest quarter (USD): Value (m); Formula and calculation Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30..
- Payables · latest quarter (USD): Value $15.07M; Formula and calculation Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30..
- Deferred revenue · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30..
- Other obligations · due within 1 year (USD): Value $12.09M; Formula and calculation Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30..
Payables and obligations
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Other obligations · latest quarter (USD) | (m) | Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Payables · latest quarter (USD) | $15.07M | Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30. Reported amount: $15.07M |
| Deferred revenue · latest quarter (USD) | (m) | Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due within 1 year (USD) | $12.09M | Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30. Reported amount: $12.09M |
| Other obligations · due after 1 year (USD) | (m) | Reported other noncurrent liabilities minus the noncurrent deferred revenue they include (total customer contract obligations − current portion); a separately reported noncurrent deferred revenue line is not deducted. The saved current-quarter facts do not separately disclose taxes, leases or other accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Total reported obligations | 139.28M USD | Liabilities |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Amounts owed to suppliers | 15.07M USD | Accounts Payable, Current |
| Total deferred revenue | (m) | Contract with Customer, Liability, Current · Contract with Customer, Liability, Noncurrent |
| Deferred revenue due within one year | 14.09M USD | Contract with Customer, Liability, Current |
| Deferred revenue due after one year | (m) | Contract with Customer, Liability, Noncurrent · Contract with Customer, Liability, Current |
| Reported other obligations due within one year | 12.09M USD | Other Liabilities, Current |
| Reported other noncurrent obligations | 91.00K USD | Other Liabilities, Noncurrent |
| Deferred revenue included in other noncurrent obligations | (m) | Contract with Customer, Liability, Current |
Other obligations breakdown
- Other obligations · due within 1 year (USD)
- $12.09M
- Other obligations · due after 1 year (USD)
- (m)
Bonds and commercial paper are already included in Total debt. Other obligations include taxes, accrued expenses and operating/finance leases. Category amounts below are the issuer’s own tagged balances at the same quarter end; untagged categories are not shown.
| Category | Quarter ending 2026-06-30 |
|---|---|
| Operating lease obligations | $25.79M |
These categories are parts of the combined obligations, not additional deductions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Other obligations | Payables | Deferred revenue | Short-term obligations | Long-term obligations | Total reported obligations (USD) | Borrowing debt (USD) | Deferred revenue due within one year (USD) | Deferred revenue due after one year (USD) | Reported other noncurrent obligations (USD) | Deferred revenue included in other noncurrent obligations (USD) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $15.07M | (m) | $12.09M | (m) | $139.28M | (m) | $14.09M | (m) | $91.00K | (m) |
| 2026-03-31 | (m) | $18.85M | (m) | $10.25M | (m) | $139.40M | (m) | $13.70M | (m) | $121.00K | (m) |
| 2025-12-31 | (m) | $17.29M | (m) | $10.07M | (m) | $142.21M | (m) | $13.05M | (m) | $147.00K | (m) |
| 2025-09-30 | (m) | $11.12M | (m) | $8.18M | (m) | $131.26M | (m) | $10.66M | (m) | $576.00K | (m) |
| 2025-06-30 | (m) | $11.78M | (m) | $9.69M | (m) | $127.26M | (m) | $9.89M | (m) | $223.00K | (m) |
| 2025-03-31 | (m) | $14.83M | (m) | $8.48M | (m) | $130.22M | (m) | $9.80M | (m) | $324.00K | (m) |
| 2024-12-31 | (m) | $10.03M | (m) | $8.09M | (m) | $131.80M | (m) | $9.56M | (m) | $324.00K | (m) |
| 2024-09-30 | (m) | $15.09M | (m) | $7.90M | (m) | $132.92M | (m) | $7.99M | (m) | $479.00K | (m) |
| 2024-06-30 | (m) | $9.95M | (m) | $7.75M | (m) | $122.57M | (m) | $6.55M | (m) | $479.00K | (m) |
| 2024-03-31 | (m) | $10.08M | (m) | $7.62M | (m) | $118.85M | (m) | $5.86M | (m) | $517.00K | (m) |
| 2023-12-31 | (m) | $13.50M | (m) | $6.32M | (m) | $123.97M | (m) | $5.66M | (m) | $517.00K | (m) |
| 2023-09-30 | (m) | $13.60M | $5.52M | $7.79M | (m) | $121.77M | (m) | $5.01M | $517.00K | (m) | $0.00 |
| 2023-06-30 | (m) | $10.04M | $5.07M | $8.89M | (m) | $116.54M | (m) | $4.72M | $357.00K | (m) | $0.00 |
| 2023-03-31 | (m) | $10.34M | (m) | $7.81M | (m) | $111.33M | (m) | $3.94M | (m) | (m) | (m) |
| 2022-12-31 | (m) | $9.39M | (m) | $7.47M | (m) | $112.26M | (m) | $2.85M | (m) | $0.00 | (m) |
| 2022-09-30 | (m) | $6.33M | (m) | $5.93M | (m) | $103.28M | (m) | $2.34M | (m) | $200.00K | (m) |
| 2022-06-30 | (m) | $3.34M | (m) | $4.26M | (m) | $71.74M | (m) | $1.86M | (m) | $200.00K | (m) |
| 2022-03-31 | (m) | $2.63M | (m) | $3.99M | (m) | $68.16M | (m) | $1.37M | (m) | $200.00K | (m) |
| 2021-12-31 | (m) | $2.03M | (m) | $4.61M | (m) | $69.93M | (m) | $1.02M | (m) | $200.00K | (m) |
| 2021-09-30 | (m) | $3.59M | (m) | $2.83M | (m) | $68.15M | (m) | $848.00K | (m) | $200.00K | (m) |
| 2020-12-31 | (m) | $1.24M | (m) | $1.98M | (m) | $65.01M | (m) | $233.00K | (m) | $200.00K | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |